Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease.
Cerebral small vessel disease results in silent ischemic lesions (SIL) among which is leukoaraiosis. In this process, endothelial damage is probably involved. Endothelial progenitor cells (EPC), are involved in endothelial repair. By restoring the damaged endothelium, EPC could mitigate SIL and cerebral small vessel disease. Haptoglobin 1-1, one of three phenotypes of haptoglobin, relates to SIL and may therefore attenuate the endothelial repair by EPC. Our aim was to quantify EPC number and function and to assess haptoglobin phenotype and its effect on EPC function in patients with a high prevalence of SIL: lacunar stroke patients. We assessed EPC In 42 lacunar stroke patients and 18 controls by flow cytometry and culture with fetal calf serum, patient and control serum. We determined haptoglobin phenotype and cultured EPC with the three different haptoglobin phenotypes. We found that EPC cluster counts were lower in patients (96.9 clusters/well +/- 83.4 (mean +/- SD)), especially in those with SIL (85.0 +/- 64.3), than in controls (174.4 +/- 112.2). Cluster formation was inhibited by patient serum, especially by SIL patient serum, but not by control serum. Patients with haptoglobin 1-1 had less clusters in culture, and when haptoglobin 1-1 was added to EPC cultures, cluster numbers were lower than with the other haptoglobin phenotypes. We conclude that lacunar stroke patients, especially those with SIL, have impaired EPC cluster formation, which may point at decreased endothelial repair potential. The haptoglobin 1-1 phenotype is likely a causative factor in this impairment.
Rouhl
R P W
RP
Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands. R.Rouhl@mumc.nl
van Oostenbrugge
R J
RJ
Damoiseaux
J G M C
JG
Debrus-Palmans
L L
LL
Theunissen
R O M F I H
RO
Knottnerus
I L H
IL
Staals
J E A
JE
Delanghe
J R
JR
Tervaert
J W Cohen
JW
Lodder
J
J
D053687:Adult Stem Cells / Q000187:drug effects / Q000502:physiology*; D000368:Aged; D015703:Antigens, CD / Q000378:metabolism; D001921:Brain / Q000473:pathology; D020520:Brain Infarction / Q000209:etiology / Q000473:pathology*; D002478:Cells, Cultured; D002561:Cerebrovascular Disorders / Q000150:complications / Q000473:pathology*; D004727:Endothelium / Q000473:pathology*; D005260:Female; D005434:Flow Cytometry; D006242:Haptoglobins / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D012189:Retrospective Studies; D012307:Risk Factors
D015703:Antigens, CD; D006242:Haptoglobins